The New Normal: A Guide for Specialty Pharmaceutical Manufacturers

The specialty pharmaceutical segment is growing at unprecedented rates, as more manufacturers focus R&D on pricier, specialty drugs to compete in an evolving marketplace.

But with great potential for success also comes great risk. With the high price tags that accompany every transaction, the impacts of any misstep in managing contracts and revenues will be substantial – and potentially life-threatening for manufacturers.

Is your organization prepared to navigate the constructs of this segment successfully?

In the e-book, “The New Normal: A Guide for Specialty Pharmaceutical Manufacturers”, we examine the new and unique challenges faced by manufacturers in the burgeoning market segment, and identify strategies for success. Read this complimentary e-book to learn more about:

• How new distribution channels affect contracting and how to effectively manage corresponding terms and conditions
• Protecting margins from revenue leakage with improved management of rebates, chargebacks, and other fees or incentives
• Improving performance and driving market growth by implementing regular, thorough analysis

The potential rewards for success in specialty pharma are unparalleled. The time to prepare is now.

Get the e-book today!